|
|
Article: FDA Approves alli(TM) (orlistat 60 mg capsules) Over-The-Counter.
- Article from:
- PR Newswire
- Article date:
- February 7, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
An Innovative and Honest Approach to Weight Loss
Combines a Safe and Effective Product With An Innovative Personalized Support Program
PITTSBURGH, Feb. 7 /PRNewswire-FirstCall/ -- GlaxoSmithKline [NYSE:GSK] Consumer Healthcare announces today that the U.S. Food and Drug Administration (FDA) approved the weight-loss product orlistat 60 mg capsules for over-the-counter (OTC) use in the United States. GSK Consumer Healthcare will market OTC orlistat under the brand name alli(TM) (pronounced AL-eye). Approved for use by overweight adults in conjunction with a reduced-calorie, low-fat diet, alli helps people lose 50 percent more weight than with diet alone. ...